Quick Answer
CorMedix Inc. reported Diluted EPS of $2.04 per share for fiscal year 2025.
CorMedix Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.04 | +780.0% |
| 2024 | -$0.30 | +67.0% |
| 2023 | -$0.91 | -23.0% |
| 2022 | -$0.74 | +1.3% |
| 2021 | -$0.75 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.26 | +2620.0% | +350.0% |
| June 30, 2025 | $0.28 | +212.0% | -6.7% |
| March 31, 2025 | $0.30 | +220.0% | +700.0% |
| September 30, 2024 | -$0.05 | +70.6% | +80.0% |
| June 30, 2024 | -$0.25 | +0.0% | +0.0% |
| March 31, 2024 | -$0.25 | -4.2% | -47.1% |
| September 30, 2023 | -$0.17 | +0.0% | +32.0% |
| June 30, 2023 | -$0.25 | -31.6% | -4.2% |
- CorMedix Inc. showed an increase of +780.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, CorMedix Inc.’s diluted eps has grown by 372.0% (from $0.75 per share (loss) to $2.04 per share).
- The most recent figure is from CorMedix Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: